Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes

Diabetes Care. 1995 Feb;18(2):241-4. doi: 10.2337/diacare.18.2.241.

Abstract

Objective: To assess whether lipoprotein(a) [Lp(a)] is a risk factor for atherosclerotic cardiovascular disease in diabetes.

Research design and methods: We studied 221 patients with non-insulin-dependent diabetes mellitus (NIDDM) without diabetic complications who were followed for 2.2-3.1 years. Their serum Lp(a) levels were semiquantified by a rapid electrophoretic method that accurately discriminates high from low serum Lp(a) at the 20 mg/dl level.

Results: Seven of 105 diabetic patients with a high serum Lp(a) experienced a clinical event related to atherosclerotic cardiovascular disease. This incidence was significantly higher than that of the 110 diabetic patients with a low serum Lp(a). The logistic regression analysis revealed that Lp(a) was an independent risk factor for the event.

Conclusions: Lp(a) is a significant risk factor for atherosclerotic cardiovascular disease in NIDDM.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Arteriosclerosis / epidemiology*
  • Biomarkers / blood
  • Blood Glucose / metabolism
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetic Angiopathies / epidemiology*
  • Female
  • Follow-Up Studies
  • Glycated Hemoglobin / analysis
  • Humans
  • Hypertension / physiopathology
  • Lipoprotein(a) / blood*
  • Male
  • Middle Aged
  • Prospective Studies
  • Regression Analysis
  • Risk Factors
  • Sex Factors
  • Smoking
  • Time Factors
  • Triglycerides / blood

Substances

  • Biomarkers
  • Blood Glucose
  • Cholesterol, HDL
  • Glycated Hemoglobin A
  • Lipoprotein(a)
  • Triglycerides
  • Cholesterol